by Maria Zannes | Jul 7, 2020 | Press Releases
OrbiMed Partner and Co-Founder of Alexion increases leadership role in oncology focused private company JULY 7, 2020 (San Antonio, TX) bioAffinity Technologies, a privately-held cancer diagnostics and therapeutics company, today announced that Stephen Squinto, Ph.D.,...
by Maria Zannes | Jun 16, 2020 | Press Releases
Philanthropist was Devoted to Bringing Life-Saving Tests and Treatments to Those In Need JUNE 16, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biomedical company, today named its research laboratories in memoriam of Harvey Sandler, a businessman...
by Maria Zannes | Jun 10, 2020 | Press Releases
Trial results of automated test demonstrate non-invasive CyPath® Lung is highly accurate in finding lung cancer FAQ: Answers to Questions about Cypath® Lung JUNE 10, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced its...
by Maria Zannes | Jan 8, 2020 | Events
State of the Industry is February 11th, 2020 at the Grand Hyatt in San Antonio, TX. The premier annual event celebrating the people of San Antonio’s healthcare and bioscience industry conveys five stories in the effort to advance human health. Maria Zannes will...
by Maria Zannes | Oct 31, 2019 | Events
7th Annual UTSA Innovation Awards Tuesday, November 12, 2019 6 p.m. Reception | 7 p.m. Dinner Eilan Hotel — Incanto Ballroom 18603 La Cantera Terrace San Antonio, TX 78256 Keynote: Maria Zannes, CEO of BioAffinity Techonlogies Inc. The annual UTSA Innovation Awards...
